vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 20.75 USD -2.35% Market Closed
Market Cap: 66.2m USD

Wall Street
Price Targets

VTVT Price Targets Summary
vTv Therapeutics Inc

Wall Street analysts forecast VTVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTVT is 36.21 USD with a low forecast of 35.35 USD and a high forecast of 37.8 USD.

Lowest
Price Target
35.35 USD
70% Upside
Average
Price Target
36.21 USD
75% Upside
Highest
Price Target
37.8 USD
82% Upside
vTv Therapeutics Inc Competitors:
Price Targets
PRQR
ProQR Therapeutics NV
494% Upside
HPHA
Heidelberg Pharma AG
293% Upside
MAAT
Maat Pharma SA
271% Upside
AZT
Arcticzymes Technologies ASA
18% Upside
ABBV
Abbvie Inc
18% Upside
OXB
Oxford BioMedica PLC
75% Upside
PRAX
Praxis Precision Medicines Inc
155% Upside
RCKT
Rocket Pharmaceuticals Inc
470% Upside

Revenue
Forecast

Revenue Estimate
vTv Therapeutics Inc

For the last 8 years the compound annual growth rate for vTv Therapeutics Inc's revenue is 6%.

6%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTVT's stock price target?
Price Target
36.21 USD

According to Wall Street analysts, the average 1-year price target for VTVT is 36.21 USD with a low forecast of 35.35 USD and a high forecast of 37.8 USD.

Back to Top